Clinical Trial Update: Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed and cisplatin in advanced, persistent, or recurrent cervical cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-01-09